Effect of depot medroxyprogesterone acetate on vaginal bleeding in the puerperium.
D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000009:adverse effects*; D008599:Menstruation Disturbances / Q000139:chemically induced*; D049590:Postpartum Period; D011247:Pregnancy; D012409:Rubella / Q000517:prevention & control; D014611:Vaccination
D003692:Delayed-Action Preparations; D008525:Medroxyprogesterone